Add to ORKGof novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinom
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Ca...
Background: Cholangiocarcinoma (CC) is an intractable cancer, arising from biliary epithelial cells,...
The worldwide incidence of cholangiocarcinoma (CC) is steadily rising, the United Kingdom incidence ...
The aim of this study was the identification of novel bio-marker candidates for the diagnosis of cho...
The poor prognosis of cholangiocarcinoma (CCA) is in part due to late diagnosis, which is currently ...
The increasing mortality rates of cholangiocarcinoma (CCA) registered during the last decades are, a...
The high mortality rate of cholangiocarcinoma (CCA) is due, in part, to the lack of non-invasive app...
Cholangiocarcinoma (CCA) is the second most common-primary liver cancer. The difficulties in diagnos...
Cholangiocarcinoma (CCA) is a malignant tumour arising from the biliary system. In Europe, this tumo...
Cholangiocarcinoma (CCA) is a malignant tumour arising from the biliary system. In Europe, this tumo...
<p>Western blotting (top) and quantification (bottom) of candidate biomarker expression in equal vol...
Abstract. Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates...
Cholangiocarcinoma (CCA) is the second most common-primary liver cancer. The difficulties in diagnos...
Cholangiocarcinoma is an uncommon and highly aggressive biliary tract malignancy with few manifestat...
8noHCC represents the sixth most common cancer worldwide and the second leading cause of cancer-rela...
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Ca...
Background: Cholangiocarcinoma (CC) is an intractable cancer, arising from biliary epithelial cells,...
The worldwide incidence of cholangiocarcinoma (CC) is steadily rising, the United Kingdom incidence ...
The aim of this study was the identification of novel bio-marker candidates for the diagnosis of cho...
The poor prognosis of cholangiocarcinoma (CCA) is in part due to late diagnosis, which is currently ...
The increasing mortality rates of cholangiocarcinoma (CCA) registered during the last decades are, a...
The high mortality rate of cholangiocarcinoma (CCA) is due, in part, to the lack of non-invasive app...
Cholangiocarcinoma (CCA) is the second most common-primary liver cancer. The difficulties in diagnos...
Cholangiocarcinoma (CCA) is a malignant tumour arising from the biliary system. In Europe, this tumo...
Cholangiocarcinoma (CCA) is a malignant tumour arising from the biliary system. In Europe, this tumo...
<p>Western blotting (top) and quantification (bottom) of candidate biomarker expression in equal vol...
Abstract. Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates...
Cholangiocarcinoma (CCA) is the second most common-primary liver cancer. The difficulties in diagnos...
Cholangiocarcinoma is an uncommon and highly aggressive biliary tract malignancy with few manifestat...
8noHCC represents the sixth most common cancer worldwide and the second leading cause of cancer-rela...
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Ca...
Background: Cholangiocarcinoma (CC) is an intractable cancer, arising from biliary epithelial cells,...
The worldwide incidence of cholangiocarcinoma (CC) is steadily rising, the United Kingdom incidence ...